Chemical Structure (Zeposia 01)
Zeposia Kit
Product Images NDC 59572-810
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 11 technical images submitted to the FDA as part of the official labeling for Zeposia (NDC 59572-810). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Celgene Corporation, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Principal Display Panel (0.92 mg Capsule Bottle Label)
Zeposia 02a
This is a medication label that describes the contents of a bottle of 30 capsules of ozanimod, which contains 0.92mg of ozanimod hydrochloride per capsule. It also includes dosage instructions, a warning not to use unless prescribed by a healthcare professional, and storage temperature requirements. A medication guide must be dispensed to each patient who receives this medication.*
Principal Display Panel (7 Capsule Starter Pack Kit Carton)
This is a description for a medication called "ZEPOSIA" that comes in a 7-day starter pack. The pack includes 7 capsules intended to be taken over 7 days. The contents of the pack include four 0.23 mg capsules and three 0.6 mg capsules. "ZEPOSIA" is the brand name for ozanimod capsules, but some of the characters in the text are non-English and may be the result of errors.*
Principal Display Panel (7 Capsule Blister Pack)
ZEPOSIA is a medication that comes in capsule form in a 7-day starter pack. The pack contains 7 capsules to be taken over 7 days. The contents of the pack include 4 capsules of 0.23mg each and 3 capsules of 0.48mg each. The dosing instructions are provided. No other information is available.*
Principal Display Panel (Kit Carton)
This is a medication guide for a drug called Zeposia or ozanimod. It is a prescription-only medication. The text provides instructions for the 7-day starter pack followed by the regular daily dosage. The starter pack consists of taking one 0.46 mg capsule of Zeposia for the first 7 days, followed by one 0.92 mg capsule a day orally from the 30-count bottle. There is also a prescription number provided - N5 67280091.*
Principal Display Panel (0.92 mg Capsule Bottle Label)
Zeposia (ozanimod) is a capsule medication with a dosage of 092 mg and it should not be sold separately. It is recommended to dispense the medication guide to each patient. The recommended dosage is 10 for presenting niomin for dosing. The manufacturer suggests storing it at a controlled room temperature of 20°C to 25°C (65°F to 77°F). It is manufactured by Somogaen (G) and made in the USA by Coona Corporation.*
Principal Display Panel (7 Capsule Blister Pack)
This text appears to be some instructions and information regarding a pharmaceutical product called "ZEPOSIA". It is a 7-day starter pack of capsules, containing different dosages for different days. There are also warnings to not sell the pack separately. The text includes some codes and numbers that may be relevant to medical professionals or patients who use this product.*
Principal Display Panel (Kit Carton)
ZEPOSIA (ozanimod) capsules are used in two steps. In the first seven days, a 7-Day Pack is completed consisting of taking one 0.23 mg capsule daily on Days 1-4, and then taking one 0.46 mg capsule daily on Days 5-7. Starting on Day 8, one 0.92 mg capsule is taken daily from the 50-count bottle. This instruction is for medical use only. It also indicates that the given material is just a sample and not for sale.*
Principal Display Panel (0.92 mg Capsule Bottle Label)
Principal Display Panel (7 Capsule Blister Pack)
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
